Laboratoires Teriak   Report issue

For profit Phase 4
Founded: Djebel Oust Tunisia (1975)
Status: No NME R&D (1975)

Organization Overview

First Clinical Trial
2018
NCT03329261
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Laboratoires Teriak

Active Ingredients

Drugs in Phase 4 Trials (1)

clopidogrel (plavix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1